Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Laurie A Fleming"'
Autor:
Erik W. Carter, Emily R. Lanchak, Laura Guest, Elise D. McMillan, Julie Lounds Taylor, Laurie P. Fleming, Anh Dao
Publikováno v:
American Journal on Intellectual and Developmental Disabilities. 128:219-236
The road to employment is not often easy for individuals with intellectual and developmental disabilities (IDD). Families know firsthand the complexities and challenges of obtaining employment for their members with extensive support needs. The purpo
Autor:
Scott S. Malinowski, T. Kristopher Harrell, Robert M. Metzger, Kristin M. Gilbert, Laurie W. Fleming, Meagan A. Brown, Elizabeth B. Hearn, Adam N. Pate
Publikováno v:
Currents in pharmacy teachinglearning. 13(10)
Introduction Matching an increasing number of pharmacy students with a limited number of advanced pharmacy practice experience (APPE) sites has become challenging for pharmacy schools. Selective tiered optimization (STO), a process for matching stude
Autor:
Jamie L. Wagner, Ashley Jones-Bodie, Courtney S. Davis, Adam N. Pate, Meagan A. Brown, Laurie W. Fleming, Joshua W. Fleming
Publikováno v:
Am J Pharm Educ
Objective. This study sought to evaluate the impact of faculty, preceptor, and student preferences for type of communication received and timeliness of communication on their perceptions of professionalism and personal value. Methods. An anonymous qu
Autor:
James J. Pitcock, Jordan M. Ballou, S. Travis King, Amanda C. Capino, Joshua W. Fleming, Kayla R. Stover, Laurie W. Fleming, Anne Marie Liles, Daniel M. Riche
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2:108-115
Autor:
Meagan A. Brown, Joshua W. Fleming, Laurie W. Fleming, Courtney S. Davis, Scott S. Malinowski
Publikováno v:
Journal of the American Association of Nurse Practitioners. 30:373-380
In the past decade, there has been much advancement in oral antidiabetic agents, but few changes in insulin therapy. With the addition of the ultra-long-acting insulins, insulin glargine U300 (IGlar 300) and insulin degludec (IDeg 100 and IDeg 200),
Publikováno v:
Journal of the American Association of Nurse Practitioners. 28:503-509
Purpose The purpose of this article is to educate nurse practitioners about the role of Toujeo®, insulin glargine U-300 (Gla-300), which is a new option for the treatment of diabetes mellitus. Data sources A comprehensive literature search was condu
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Canagliflozin-metformin is one of the newest combination therapies available for the treatment of type 2 diabetes mellitus (T2DM). Canagliflozin is an inhibitor of the sodium-glucose co-transporter 2 which causes an increase in the urinary excretion
Publikováno v:
Journal of the American Pharmacists Association. 59:S117-S121.e2
In July 2017, Mississippi passed House Bill 996, which permitted first responders to carry naloxone and required training before administration. There is no standard training offered in Mississippi for first responders. The purpose was to evaluate th
Autor:
Meagan A. Brown, Laurie W. Fleming, Joshua W. Fleming, Scott S. Malinowski, Courtney S. Davis, Shirley Hogan
Publikováno v:
Currents in pharmacy teachinglearning. 9(3)
Background and purpose The purpose of this study was to evaluate the success of a faculty Research/Writing Group (RWG) by quantifying the amount of scholarly productivity from participants in the group compared with that of a matched cohort. Educatio
Publikováno v:
Journal of the American Association of Nurse Practitioners. 27(10)
The purpose of this article is to educate nurse practitioners about Afrezza.A comprehensive literature search was conducted using MEDLINE for clinical trial data. Information from the Centers of Disease Control and Prevention, World Health Organizati